Get the Stockscreener App
3.27
2.10%
-0.07
Grace Therapeutics Inc stock is traded at $3.27, with a volume of 43,859.
It is down -2.10% in the last 24 hours and down -22.51% over the past month.
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.
See More
Previous Close:
$3.34
Open:
$3.35
24h Volume:
43,859
Relative Volume:
0.71
Market Cap:
$34.07M
Revenue:
-
Net Income/Loss:
$-11.61M
P/E Ratio:
-2.5259
EPS:
-1.2946
Net Cash Flow:
$-11.82M
1W Performance:
-0.91%
1M Performance:
-22.51%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$3.26
$3.55
1-Week Range:
$3.06
$3.55
52-Week Range:
$2.88
$4.965
Grace Therapeutics Inc Stock (GRCE) Company Profile
Name
Grace Therapeutics Inc
Sector
Industry
Phone
609-322-1602
Address
103 CARNEGIE CENTER, PRINCETON
Compare GRCE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRCE
Grace Therapeutics Inc
|
3.26 | 34.07M | 0 | -11.61M | -11.82M | -1.2946 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.26 | 122.13B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
715.32 | 78.30B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
648.70 | 39.73B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
277.02 | 35.50B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
118.43 | 28.47B | 3.30B | -501.07M | 1.03B | -2.1146 |
Grace Therapeutics Inc Stock (GRCE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-01-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-06-20 | Upgrade | B. Riley FBR | Neutral → Buy |
| Jan-13-20 | Downgrade | B. Riley FBR | Buy → Neutral |
| Aug-29-19 | Initiated | B. Riley FBR | Buy |
| Jul-18-19 | Initiated | Oppenheimer | Outperform |
| Jun-26-19 | Initiated | H.C. Wainwright | Buy |
View All
Grace Therapeutics Inc Stock (GRCE) Latest News
MaRS appoints Grace Lee Reynolds as CEO and welcomes new leaders to the board - Yahoo Finance
Corcept Therapeutics stock soars to all-time high of $70.78 - MSN
University President Mourns Student Who Died in Midair Collision - Yahoo Finance
The Orlando Credit Union Charitable Foundation Opens Applications for 2025 Grace Chewning Scholarship Fund - Yahoo Finance
Viracta Therapeutics strikes deal to avoid default - MSN
3 US Penny Stocks With Market Cap Under $70M - Simply Wall St
Nav Welcomes Grace Liu as Chief Financial Officer - Yahoo Finance
HEAVY.AI Announces Availability of Analytics Platform Accelerated by NVIDIA Grace Hopper Superchip - Yahoo Finance
Woolworths, Coles' horror $4.1 billion fall from grace: 'Very significant' - Yahoo Finance Australia
ABVC BioPharma, Inc. Granted Additional 180-Day Grace Period to Regain Compliance With Nasdaq Bid Price Requirement - Yahoo Finance
EPF introduces faster access, monthly activation for Simpanan Shariah - The Malaysian Reserve
Traumatic Brain Injury Pipeline Insights 2024: Therapies, Clinical Trials, and Treatment Outlook | Neuren Pharma, NeuroVive Pharma, Stemedica Cell Techn, Grace Laboratories, Integra LifeSciences Corp - The Globe and Mail
Traumatic Brain Injury Pipeline Insights 2024: Therapies, - openPR
Nvidia debuts GB10 superchip, AI systems for humanoid robots, self-driving trucks at CES 2025 - Yahoo Finance
Grace Therapeutics to Participate in Upcoming Investor Events January 2025 - The Manila Times
Grace Therapeutics to Present Novel aSAH Treatment at Major January Healthcare Events - StockTitan
NVIDIA Puts Grace Blackwell on Every Desk and at Every AI Developer’s Fingertips - Yahoo Finance
Delta's 'saving grace' for Q4 will be lower fuel prices: Analyst - Yahoo Finance
China's No 2 chip foundry Hua Hong names former Intel veteran as new president - Yahoo Finance
Corcept Therapeutics Submits FDA Application for Breakthrough Cushing's Syndrome Treatment Relacorilant - StockTitan
Nvidia unveils GB200 NVL4 with two Grace CPUs and four Blackwell GPUs for modern data center workloads - Yahoo Finance
Steve Kimock: All You Need Is Love - MetroWest Daily News
A secretary turned $180 into $7.2 million by holding her employer's stock for 75 years - Yahoo Finance
Grace Therapeutics And 2 Other US Penny Stocks Worth Watching - Simply Wall St
Zepbound, Mounjaro shortages are resolved, FDA confirms - BioPharma Dive
A new era of targeted therapy with antibody–drug conjugates - News-Medical.Net
CORTCorcept Therapeutics Inc. Latest Stock News & Market Updates - StockTitan
CORT's Dazucorilant Fails to Meet Goal in Neurologic Disorder Study - MSN
Stretch Your Dollar: Users save hundreds by automating FSA claims for purchases - Yahoo Finance
GRCE: aSAH KOL Summary - Zacks Small Cap Research
Crown Labs announces merger with Revance Therapeutics | News - Johnson City Press
SUBARU ANNOUNCES 2025 SUBARU WINTERFEST LOCATIONS AND MUSIC LINEUP WITH HEADLINER GRACE POTTER - Yahoo Finance
Acasti Pharma stock soars to 52-week high of $3.61 By Investing.com - Investing.com Canada
A.C. Grace's UNIQUE E Reaffirmed as ConsumerLab.com's Top Pick for Natural Vitamin E - Yahoo Finance
Acasti Pharma stock soars to 52-week high of $3.61 - Investing.com India
Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare Division - The Manila Times
Grace Therapeutics to Showcase Novel aSAH Treatment at Major ASHP Clinical Meeting Ahead of Phase 3 Data - StockTitan
Acasti Pharma to Report Third Quarter 2023 Financial Results on Tuesday, February 14, 2023 - Quantisnow
Iteos Therapeutics Inc (ITOS-Q) QuotePress Release - The Globe and Mail
Arm Holdings plc (ARM) Showcases Power Efficiency with NVIDIA’s 72-Core Grace CPU - Yahoo Finance
Grace Therapeutics Reports Steady Progress and Financials - TipRanks
GRCE (Grace Therapeutics) Total Inventories : $0.00 Mil (As of Sep. 2024) - GuruFocus.com
GRCE: FY:25 Second Quarter Results - MSN
WEKA Unveils Industry's First AI Storage Cluster Built On NVIDIA Grace CPU Superchips - Yahoo Finance
Twist Bioscience rises 13% on FQ4 earnings beats, 2025 revenue outlook - MSN
Altair Solutions Now Supported on NVIDIA Grace Hopper and Grace CPU Superchip Architectures - Yahoo Finance
Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateOn November 13, 2024, Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company focusing on innovative therapies for rare cardiopulmonary dise - Defense World
Horizon Space Acquisition I Corp. Approved for Listing on Nasdaq Capital Market - Defense World
Seres Therapeutics Receives Notification from Nasdaq Regarding Bid Price Requirement - Defense World
Chain Bridge I Faces Delisting from Nasdaq Due to Non-Compliance with Listing Rule - Defense World
BioRestorative Therapies Provides Business Update and Financial Results for Q3 2024 - Defense World
Grace Therapeutics Inc Stock (GRCE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.59%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):